FRIDAY, April 13 (HealthDay News) -- An antibiotic ointment called Altabax (retapamulin) has been approved to treat children and adults with a bacterial skin infection called impetigo, the U.S. Food and Drug Administration said Friday.
The drug, a new molecular entity not previously approved in the United States, can be used on people aged nine months or older, the FDA said.
The approval was based on a study of about 3,000 people who received either Altabax, different antibiotics, or a non-medicinal placebo. The most common side effect among those using Altabax was irritation at the site where it was applied. This occurred in less than two percent of people who used the ointment, the FDA said.
Altabax, which will be available by prescription, is made by North Carolina-based GlaxoSmithKline.
Visit the FDA to learn more about this approval.